314 related articles for article (PubMed ID: 33480665)
1. A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Bosheva M; Gujabidze R; Károly É; Nemeth A; Saulay M; Smart JI; Hamed KA
Pediatr Infect Dis J; 2021 Jun; 40(6):e222-e229. PubMed ID: 33480665
[TBL] [Abstract][Full Text] [Related]
2. Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
Syed YY
Drugs; 2014 Sep; 74(13):1523-42. PubMed ID: 25117196
[TBL] [Abstract][Full Text] [Related]
3. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
Awad SS; Rodriguez AH; Chuang YC; Marjanek Z; Pareigis AJ; Reis G; Scheeren TW; Sánchez AS; Zhou X; Saulay M; Engelhardt M
Clin Infect Dis; 2014 Jul; 59(1):51-61. PubMed ID: 24723282
[TBL] [Abstract][Full Text] [Related]
4. Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.
Scheeren TWL; Welte T; Saulay M; Engelhardt M; Santerre-Henriksen A; Hamed K
BMC Infect Dis; 2019 Feb; 19(1):195. PubMed ID: 30808293
[TBL] [Abstract][Full Text] [Related]
5. Ceftobiprole for the treatment of pneumonia: a European perspective.
Liapikou A; Cillóniz C; Torres A
Drug Des Devel Ther; 2015; 9():4565-72. PubMed ID: 26316697
[TBL] [Abstract][Full Text] [Related]
6. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
Nicholson SC; Welte T; File TM; Strauss RS; Michiels B; Kaul P; Balis D; Arbit D; Amsler K; Noel GJ
Int J Antimicrob Agents; 2012 Mar; 39(3):240-6. PubMed ID: 22230331
[TBL] [Abstract][Full Text] [Related]
7. A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
Blumer JL; Ghonghadze T; Cannavino C; O'Neal T; Jandourek A; Friedland HD; Bradley JS
Pediatr Infect Dis J; 2016 Jul; 35(7):760-6. PubMed ID: 27078119
[TBL] [Abstract][Full Text] [Related]
8. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
9. Ceftobiprole and pneumonia in adults admitted to the emergency department is it time to assess a new therapeutic algorithm?
Crapis M; Venturini S; Della Siega P; Tonizzo M; Garlatti E; Rosa R; Basso B; Pontoni E
J Chemother; 2021 May; 33(3):174-179. PubMed ID: 32996844
[TBL] [Abstract][Full Text] [Related]
10. Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Overcash JS; Kim C; Keech R; Gumenchuk I; Ninov B; Gonzalez-Rojas Y; Waters M; Simeonov S; Engelhardt M; Saulay M; Ionescu D; Smart JI; Jones ME; Hamed KA
Clin Infect Dis; 2021 Oct; 73(7):e1507-e1517. PubMed ID: 32897367
[TBL] [Abstract][Full Text] [Related]
11. Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
Noel GJ; Strauss RS; Amsler K; Heep M; Pypstra R; Solomkin JS
Antimicrob Agents Chemother; 2008 Jan; 52(1):37-44. PubMed ID: 17954698
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Noel GJ; Bush K; Bagchi P; Ianus J; Strauss RS
Clin Infect Dis; 2008 Mar; 46(5):647-55. PubMed ID: 18225981
[TBL] [Abstract][Full Text] [Related]
13. Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia.
Scheeren TW
Future Microbiol; 2015; 10(12):1913-28. PubMed ID: 26573022
[TBL] [Abstract][Full Text] [Related]
14. Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis.
Eljaaly K; Wali H; Basilim A; Alharbi A; Asfour HZ
Int J Antimicrob Agents; 2019 Aug; 54(2):149-153. PubMed ID: 31173864
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients.
Rubino CM; Polak M; Schröpf S; Münch HG; Smits A; Cossey V; Tomasik T; Kwinta P; Snariene R; Liubsys A; Gardovska D; Hornik CD; Bosheva M; Ruehle C; Litherland K; Hamed K
Pediatr Infect Dis J; 2021 Nov; 40(11):997-1003. PubMed ID: 34533489
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.
Torres A; Mouton JW; Pea F
Clin Pharmacokinet; 2016 Dec; 55(12):1507-1520. PubMed ID: 27272266
[TBL] [Abstract][Full Text] [Related]
17. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
Lodise TP; Low DE
Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432
[TBL] [Abstract][Full Text] [Related]
18. Ceftobiprole medocaril for the treatment of community-acquired pneumonia.
Falcó V; Burgos J; Almirante B
Expert Opin Pharmacother; 2018 Sep; 19(13):1503-1509. PubMed ID: 30198789
[TBL] [Abstract][Full Text] [Related]
19. Ceftobiprole for the treatment of pneumonia.
Cillóniz C; Dominedò C; Garcia-Vidal C; Torres A
Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):17-23. PubMed ID: 31364337
[TBL] [Abstract][Full Text] [Related]
20. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley IA; Thye DA;
J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii19-32. PubMed ID: 21482566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]